Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Surveillance Study (Paper-AWB) for GPs and Clinics: Treatment of Opioid-dependent Patients With SUBOXONE® 2 mg / 8 mg Sublingual Tablets - Acceptability and Safety Data From a Real Life Scenario.

NCT00723749 is registered in ClinicalTrials.gov with Indivior Inc. as lead sponsor.

NCT NCT00723749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00723749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Surveillance Study (Paper-AWB) for GPs and Clinics: Treatment of Opioid-dependent Patients With SUBOXONE® 2 mg / 8 mg Sublingual Tablets - Acceptability and Safety Data From a Real Life Scenario.
Lead sponsor
Indivior Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2008
Completion date
December 31, 2010
Enrollment
384 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

drug abuse, opiate dependence, opioid-related disorders